Filing Details
- Accession Number:
- 0001225208-17-010017
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-05-17 20:48:27
- Reporting Period:
- 2017-05-16
- Filing Date:
- 2017-05-17
- Accepted Time:
- 2017-05-17 20:48:27
- Original Submission Date:
- 2017-05-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 21665 | Colgate Palmolive Co | CL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 131815595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1182210 | M Ellen Hancock | C/O Colgate-Palmolive Company 300 Park Avenue New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-15 | 5,780 | $60.45 | 203,582 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 2,512 | $0.00 | 206,094 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-05-15 | 4,920 | $71.75 | 201,174 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-05-15 | 5,780 | $0.00 | 5,780 | $60.45 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2017-05-15 | 5,703 | $0.00 | 5,703 | $71.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-05-13 | No | 4 | M | Direct | |
| 5,703 | 2018-05-15 | 2023-05-15 | No | 4 | A | Direct |
Footnotes
- This amendment is filed solely to report the transactions that were inadvertently omitted from the Reporting Person's Form 4 filed on May 17, 2017.
- Exercise of stock options awarded under the issuer's incentive compensation plan.
- Annual director stock grant under the issuer's incentive compensation plan.
- Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.75 to $71.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2013 grant date.
- Annual director stock option grant under the issuer's incentive compensation plan.
- Option becomes exercisable in one-third increments beginning on the first anniversary of the grant date.
Billionaire Hedge Funds
